Folic Acid Supplementation and Risk of Gestational Diabetes Mellitus: A Systematic Review of the Literature
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26167977 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alejandro Salvador Gómez-Cabrera und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciencias Biomédicas, División de Ciencias de la Salud, Centro Universitario de Tonalá, Universidad de Guadalajara, Tonalá 45425, Jali…. Hauptthemen laut MEDLINE: Diabetes, Gestational, Folic Acid, Dietary Supplements. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Gestational diabetes mellitus (GDM) affects approximately 14% of pregnancies globally and has been hypothesized to be influenced by periconceptional and early pregnancy folic acid (FA) supplementation, a practice recommended to prevent neural tube defects. To evaluate this association, we conducted a systematic review of studies published between 2015 and 2024 examining FA use and GDM risk. Twelve studies met the inclusion criteria, including ten cohort studies and two case-control studies. While findings were mixed, several prospective studies suggested that high daily FA intake (≥800 μg) or prolonged use (>3–6 months) may be associated with increased odds of GDM, especially when initiated preconceptionally. Conversely, standard-dose supplementation (≈400 μg) appeared neutral or potentially protective in some populations. Notably, high folate status combined with low vitamin B12 was linked to increased GDM risk, suggesting metabolic interaction. Overall, most studies were of moderate to high methodological quality. Although current evidence is inconclusive, these results support cautious use of high-dose FA supplementation and the importance of individualized prenatal nutrition, particularly considering B12 status. Further research is needed to clarify biological mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Ciencias Biomédicas, División de Ciencias de la Salud, Centro Universitario de Tonalá, Universidad de Guadalajara, Tonalá 45425, Jalisco, Mexico.
- Departamento de Ciencias de la Salud-Enfermedad como Proceso Individual, División de Ciencias de la Salud, Centro Universitario de Tonalá, Universidad de Guadalajara, Tonalá 45425, Jalisco, Mexico.
- Unidad de Intervención de Medicina Crítica, Hospital General de Occidente, Secretaría de Salud Jalisco, Zapopan 45170, Jalisco, Mexico.
ORCID-Profile: Alejandro Salvador Gómez-Cabrera, Ana Elizabeth González-Santiago, Rolando Castañeda-Arellano, Fernanda Isadora Corona-Meraz, Raúl Cuauhtemoc Baptista-Rosas, María Guadalupe Sánchez-Parada
Zitieren
APA
Gómez-Cabrera, A. S., González-Santiago, A. E., Castañeda-Arellano, R., Corona-Meraz, F. I., Baptista-Rosas, R. C., & Sánchez-Parada, M. G. (2025). Folic Acid Supplementation and Risk of Gestational Diabetes Mellitus: A Systematic Review of the Literature. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167977
Vancouver
Gómez-Cabrera AS, González-Santiago AE, Castañeda-Arellano R, Corona-Meraz FI, Baptista-Rosas RC, Sánchez-Parada MG. Folic Acid Supplementation and Risk of Gestational Diabetes Mellitus: A Systematic Review of the Literature. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167977
BibTeX
@article{GmezCabrera2025,
author = {Gómez-Cabrera, Alejandro Salvador and González-Santiago, Ana Elizabeth and Castañeda-Arellano, Rolando and Corona-Meraz, Fernanda Isadora and Baptista-Rosas, Raúl Cuauhtemoc and Sánchez-Parada, María Guadalupe},
title = {Folic Acid Supplementation and Risk of Gestational Diabetes Mellitus: A Systematic Review of the Literature},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26167977}
}
EUVIMED